Hikal has informed that it has enclosed a copy of the press release on 5th May 2021, titled ‘Hikal signs a 10-year multi product deal with a leading global pharmaceutical innovator company’ regarding long term contract entered into by the Company with a leading global pharmaceutical innovator company. Treat this as an intimation under Regulation 30 of SEBI LODR.
The above information is a part of company’s filings submitted to BSE.